Global Companion Diagnostics Partnering Deal Trends, Players, Financials and Forecasts Report 2018

Dublin, April 18, 2018 -- The "Global Companion Diagnostics Partnering 2010-2018: Deal trends, players, financials and forecasts" report has been added to ResearchAndMarkets.com's offering.

The Global Companion Diagnostics Partnering 2010-2018 report provides comprehensive understanding and unprecedented access to the companion diagnostics partnering deals and agreements entered into by the worlds leading healthcare companies. This report provides details of the latest Companion Diagnostics agreements announced in the life sciences since 2010.

The report takes the reader through a comprehensive review Companion Diagnostics deal trends, key players, top deal values, as well as deal financials, allowing the understanding of how, why and under what terms, companies are entering Companion Diagnostics partnering deals.

The report presents financial deal term values for Companion Diagnostics deals, listing by headline value, upfront payments, milestone payments and royalties, enabling readers to analyse and benchmark the financial value of deals.

In conclusion, this report provides everything a prospective dealmaker needs to know about partnering in the research, development and commercialization of Companion Diagnostics technologies and products.

Key benefits

• In-depth understanding of Companion Diagnostics deal trends since 2010
• Access to headline, upfront, milestone and royalty data
• Analysis of the structure of Companion Diagnostics agreements with numerous real life case studies
• Detailed access to actual Companion Diagnostics contracts entered into by leading biopharma companies
• Identify most active Companion Diagnostics dealmakers since 2010
• Insight into terms included in a Companion Diagnostics partnering agreement, with real world examples
• Understand the key deal terms companies have agreed in previous deals
• Undertake due diligence to assess suitability of your proposed deal terms for partner companies

Available deals are listed by:

• Company A-Z
• Headline value
• Stage of development at signing
• Deal component type
• Specific therapy target
• Technology type

Key Topics Covered:

Executive Summary

Chapter 1 - Introduction

Chapter 2 - Trends in Companion Diagnostics dealmaking

2.1. Introduction
2.2. Companion Diagnostics partnering over the years
2.3. Most active Companion Diagnostics dealmakers
2.4. Companion Diagnostics partnering by deal type
2.5. Companion Diagnostics partnering by therapy area
2.6. Deal terms for Companion Diagnostics partnering
2.6.1 Companion Diagnostics partnering headline values
2.6.2 Companion Diagnostics deal upfront payments7
2.6.3 Companion Diagnostics deal milestone payments
2.6.4 Companion Diagnostics royalty rates

Chapter 3 - Leading Companion Diagnostics deals

3.1. Introduction
3.2. Top Companion Diagnostics deals by value

Chapter 4 - Most active Companion Diagnostics dealmakers

4.1. Introduction
4.2. Most active Companion Diagnostics dealmakers
4.3. Most active Companion Diagnostics partnering company profiles

Chapter 5 - Companion Diagnostics contracts dealmaking directory

5.1. Introduction
5.2. Companion Diagnostics contracts dealmaking directory

Chapter 6 - Companion Diagnostics dealmaking by technology type

Chapter 7 - Partnering resource center

7.1. Online partnering
7.2. Partnering events
7.3. Further reading on dealmaking

Appendices

Appendix 1 - Companion Diagnostics deals by company A-Z
Appendix 2 - Companion Diagnostics deals by stage of development
Appendix 3 - Companion Diagnostics deals by deal type
Appendix 4 - Companion Diagnostics deals by therapy area
Appendix 5 - Deal type definitions

For more information about this report visit https://www.researchandmarkets.com/research/zwgkqx/global_companion?w=12

CONTACT: ResearchAndMarkets.com
         Laura Wood, Senior Manager
         [email protected]
         For E.S.T Office Hours Call 1-917-300-0470
         For U.S./CAN Toll Free Call 1-800-526-8630
         For GMT Office Hours Call +353-1-416-8900
         Related Topics: Diagnostics, In Vitro Diagnostics